RE:FutureAgreed.
Fundamentally the company is now in the best position it has ever been.
Bioavailability with low cost PGX substrates which can carry bioactives (which on their own are not water soluable ) to desired tissues is the proof of concept that Ceapro needed to move forward to commerical applications of PGX. Cash on hand is able to fund the scale up of a mid sized commercial plant.